Correspondence 0001104659-23-063914 from Milestone Pharmaceuticals Inc. (MIST) (CIK 0001408443) (MIST)
Milestone Pharmaceuticals Inc. (MIST) (CIK 0001408443)
Date: May 24, 2023 · CIK: 0001408443 · Accession: 0001104659-23-063914
AI Filing Summary & Sentiment
File numbers found in text: 333-271949
Letter
Milestone Pharmaceuticals Inc.
1111 Dr. Frederik-Philips Boulevard, Suite 420
Montréal, Québec CA H4M 2X6
VIA EDGAR
May 24, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jason Drory
Re: Milestone Pharmaceuticals Inc.
Registration Statement on Form S-3, as amended
File No. 333-271949
Acceleration Request
Requested Date: Friday, May 26, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-271949) (as amended to date, the “Registration Statement”) to become effective on Friday, May 26, 2023 at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes each of Ryan Sansom and Nicolas H.R. Dumont of Cooley LLP to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Nicolas H.R. Dumont of Cooley LLP, counsel to the undersigned registrant, at (212) 479-6446.
[Signature Page Follows]
Sincerely,
Milestone Pharmaceuticals Inc.
Show Raw Text
CORRESP
1
filename1.htm
Milestone Pharmaceuticals Inc.
1111 Dr. Frederik-Philips Boulevard, Suite 420
Montréal, Québec CA H4M 2X6
VIA EDGAR
May 24, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jason Drory
Re:
Milestone Pharmaceuticals Inc.
Registration Statement on Form S-3, as amended
File No. 333-271949
Acceleration Request
Requested Date:
Friday, May 26, 2023
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and
Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-271949)
(as amended to date, the “Registration Statement”) to become effective on Friday, May 26, 2023 at
4:00 p.m. Eastern Time, or as soon thereafter as is practicable.
The Registrant hereby authorizes each of Ryan Sansom and Nicolas H.R.
Dumont of Cooley LLP to make such request on its behalf.
Once the Registration Statement has been declared
effective, please orally confirm that event with Nicolas H.R. Dumont of Cooley LLP, counsel to the undersigned registrant, at (212) 479-6446.
[Signature
Page Follows]
Sincerely,
Milestone Pharmaceuticals Inc.
By:
/s/ Joseph Oliveto
Joseph Oliveto
Chief Executive Officer
cc:
Amit Hasija, Milestone Pharmaceuticals Inc.
Ryan Sansom, Cooley LLP
Nicolas H.R. Dumont, Cooley LLP